These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 34073805)
121. Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models. Wang S; Wen H; Fei W; Zhao Y; Feng Y; Kuang L; Wang M; Wu M Am J Cancer Res; 2020; 10(8):2387-2408. PubMed ID: 32905508 [TBL] [Abstract][Full Text] [Related]